Tower Research Capital LLC (Trc) Jounce Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.9 - $1.85 $4,457 - $9,163	-4,953 Reduced 47.3%	5,519 $10,000
Q4 2022 Feb 10, 2023	BUY	$0.64 - $1.99 $1,852 - $5,761	2,895 Added 38.21%	10,472 $12,000
Q3 2022 Nov 10, 2022	SELL	$2.73 - $4.92 $8,438 - $15,207	-3,091 Reduced 28.97%	7,577 $18,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $7.67 $24,040 - $65,854	8,586 Added 412.39%	10,668 $32,000
Q1 2022 May 12, 2022	BUY	$6.01 - $8.54 $799 - $1,135	133 Added 6.82%	2,082 $14,000
Q4 2021 Feb 14, 2022	SELL	$7.11 - $9.64 $25,261 - $34,250	-3,553 Reduced 64.58%	1,949 $16,000
Q3 2021 Nov 15, 2021	SELL	$5.04 - $8.73 $23,743 - $41,127	-4,711 Reduced 46.13%	5,502 $41,000
Q2 2021 Aug 16, 2021	BUY	$6.58 - $10.66 $33,827 - $54,803	5,141 Added 101.36%	10,213 $70,000
Q1 2021 May 17, 2021	SELL	$6.73 - $13.87 $66,283 - $136,605	-9,849 Reduced 66.01%	5,072 $52,000
Q4 2020 Feb 16, 2021	SELL	$6.37 - $10.33 $40,602 - $65,843	-6,374 Reduced 29.93%	14,921 $105,000
Q3 2020 Nov 16, 2020	BUY	$4.58 - $10.95 $79,234 - $189,435	17,300 Added 433.04%	21,295 $173,000
Q2 2020 Aug 13, 2020	BUY	$4.17 - $7.58 $16,659 - $30,282	3,995 New	3,995 $28,000
Q1 2020 May 15, 2020	SELL	$2.91 - $8.7 $33,636 - $100,563	-11,559 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$2.81 - $9.21 $12,684 - $41,573	-4,514 Reduced 28.08%	11,559 $101,000
Q3 2019 Nov 05, 2019	BUY	$3.33 - $4.93 $45,830 - $67,851	13,763 Added 595.8%	16,073 $54,000
Q2 2019 Aug 13, 2019	BUY	$4.3 - $6.73 $6,643 - $10,397	1,545 Added 201.96%	2,310 $11,000
Q1 2019 May 14, 2019	SELL	$3.43 - $6.87 $24,558 - $49,189	-7,160 Reduced 90.35%	765 $4,000
Q4 2018 Feb 14, 2019	BUY	$2.69 - $6.71 $5,856 - $14,607	2,177 Added 37.87%	7,925 $26,000
Q3 2018 Nov 13, 2018	BUY	$6.5 - $8.37 $37,362 - $48,110	5,748 New	5,748 $38,000
Q2 2018 Aug 15, 2018	SELL	$7.27 - $21.88 $10,018 - $30,150	-1,378 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.4 - $28.4 $14,699 - $31,154	1,097 Added 390.39%	1,378 $31,000
Q4 2017 Feb 09, 2018	SELL	$12.52 - $17.82 $41,629 - $59,251	-3,325 Reduced 92.21%	281 $4,000
Q3 2017 Nov 14, 2017	BUY	$11.17 - $16.99 $40,279 - $61,265	3,606	3,606 $56,000

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account